It's interesting currently the latest immunotherapies for Melanoma are far more expensive than SIRT to give PFS 11 months compared to what we are getting with in mCRC - 7.9 months.
$1M compared to the cost of spheres $20-40K (single or bi-lobar therapy)- talking about the medication only, not other costs like staff, hospital stay etc.
OF course these are different tumours etc.
http://www.medscape.com/viewarticle/845707?src=wnl_edit_cfna&uac=164506DK
The article says clearly prices have to move (i.e. they are unaffordable).
Immunotherapy, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.8¢ |
Change
0.003(1.43%) |
Mkt cap ! $75.34M | |||
| Open | High | Low | Value | Volume |
| 17.8¢ | 17.8¢ | 17.5¢ | $9.047K | 50.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 7293686 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1399496 | 11 |
View Market Depth
| Last trade - 15.01pm 26/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |